◀ Back to CRH
CRH — VEGFA
Text-mined interactions from Literome
Cao et al., J Immunol 2005
:
Human mast cells express corticotropin releasing hormone (CRH) receptors and
CRH leads to selective secretion of
vascular endothelial growth factor ...
CRH increased cAMP and induced secretion of
vascular endothelial growth factor ( VEGF ) without tryptase, histamine, IL-6, IL-8, or TNF-alpha release ...
CRH stimulated
VEGF production was mediated through activation of adenylate cyclase and increased cAMP, as evidenced by the fact that the effect of CRH was mimicked by the direct adenylate cyclase activator forskolin and the cell-permeable cAMP analog 8-bromo-cAMP, whereas it was abolished by the adenylate cyclase inhibitor SQ22536 ... This is the first evidence that mast cells express functional CRH receptors and that
CRH can
induce VEGF secretion selectively
Cao et al., Mol Pharmacol 2006
:
Corticotropin releasing hormone induces
vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen activated protein kinase pathway ... However, the precise mechanism by which
CRH induces
VEGF secretion has not yet been defined ... Here, we show that
CRH induced
VEGF release was dose-dependently inhibited by the specific protein kinase A inhibitor N- [ 2- ( 4-bromocinnamylamino ) ethyl ] -5-isoquinoline ( H89 ) or the p38 mitogen activated protein kinase ( MAPK ) inhibitor 4- ( 4-fluorophenyl ) -2- ( 4-methylsulfinylphenyl ) -5- ( 4-pyridyl ) 1H-imidazole ( SB203580 ) but not by the specific inhibitor 2'-amino-3'-methoxyflavone ( PD98059 ) of mitogen activated protein kinase kinase, the upstream kinase of the extracellular signal regulated protein kinase ( ERK ) or the c-Jun N-terminal kinase (JNK) inhibitor 1,9-pyrazoloanthrone anthra- ( 1,9-cd ) pyrazol-6 ( 2H ) -one ( SP600125 ) ... These results indicate that
CRH induces
VEGF release in human mast cells via selective activation of the cAMP/protein kinase A/p38 MAPK signaling pathway, thereby providing further insight into the molecular mechanism of how CRH affects the release of a key proinflammatory mediator
Cao et al., J Urol 2006
(Acute Disease) :
Acute stress and intravesical
corticotropin releasing hormone induces mast cell dependent
vascular endothelial growth factor release from mouse bladder explants ... We investigated the
effect of intravesical
corticotropin releasing hormone and acute restraint stress on
vascular endothelial growth factor release from mouse bladder explants and the role of mast cells ...
Corticotropin releasing hormone ( 100 nM ) or acute restraint stress ( 4 hours )
increased histamine release in urine and
vascular endothelial growth factor release in medium without increasing interleukin-6 or tumor necrosis factor-alpha in the bladder explants of C57BL/6 or +/+ but not W/W ( v ) mice ... Intravesical
corticotropin releasing hormone and acute restraint stress
induced mast cell dependent
vascular endothelial growth factor release from bladder explants
Kamat et al., Cancer Lett 2007
(Anoxia...) :
In addition, we found increased HIF mediated transactivation and increased
VEGF release with decreased HIF-1alpha/p53 and HIF-1alpha/MDM-2 partnering in p53-MUT versus p53-WT cells in
response to
CRH
Wakahashi et al., Endocrine 2008
:
Effects of
corticotropin releasing hormone and stresscopin on
vascular endothelial growth factor mRNA expression in cultured early human extravillous trophoblasts ... In the present study, we investigated the
effects of
CRH and SCP on
VEGF expression in early placental extravillous trophoblasts ( EVTs ) ... The
effects of
CRH and SCP on
VEGF mRNA levels in cultured EVTs were assessed by real-time RT-PCR ... We demonstrated that
CRH and SCP
inhibited VEGF mRNA expression in cultured EVTs through the interaction with CRHR-2, suggesting that CRH and SCP may inhibit angiogenesis during early placentation
Zhou et al., Regul Pept 2010
:
To determine whether CRH and its receptor, CRH-R1, modulate the expression of vascular endothelial growth factor ( VEGF ), which is overexpressed in psoriatic epidermis and plays a causal role in the pathogenesis of psoriasis, we investigated the
effect of
CRH on the expression of
VEGF in a human keratinocyte cell line ( HaCaT ) and whether this effect is via the mitogen activated protein kinase ( MAPK ) signal transduction pathways ... However, this downregulation was abrogated by pretreatment with antalarmin, SB203580 and SP600125 ; pretreatment with PD98059 did not attenuate the
effects of
CRH on the expression of
VEGF
Boucher et al., BJU Int 2010
(Acute Disease...) :
Corticotropin releasing hormone-receptor 2 is
required for acute stress induced bladder vascular permeability and release of
vascular endothelial growth factor
Asadi et al., Journal of neuroinflammation 2012
:
Corticotropin releasing hormone and extracellular mitochondria
augment IgE stimulated human mast-cell
vascular endothelial growth factor release, which is inhibited by luteolin ...
CRH augmented IgE/anti-IgE induced human mast-cell release of
VEGF and it also induced the expression of IgE receptor ( FceRI ) on mast cells
Alysandratos et al., PloS one 2012
:
Here we show that NT triggered human mast cell degranulation and significantly augmented
CRH induced
vascular endothelial growth factor ( VEGF ) release